Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2005-05-31
2005-05-31
Scheiner, Laurie (Department: 1648)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C424S143100, C424S278100, C424S178100, C436S006000, C514S04400A, C536S023100, C530S387100
Reexamination Certificate
active
06900299
ABSTRACT:
There is provided a method of preventing a respiratory infection by administering an effective amount of an agent for regulating ICAM-1 expression. Also provided is a composition for the prevention of respiratory infection including an agent which regulates ICAM expression. method of preventing RSV infection by administering an effective amount of an agent that interferes with the binding of RSV to ICAM-1. A method of preventing RSV infection by administering an effective amount of an agent that down regulates the expression of ICAM-1, thereby decreasing RSV binding to ICAM-1 is also provided. There is provided a method of treating RSV infection by administering an effective amount of an agent for down regulating ICAM-1 expression. A method of blocking RSV-ICAM-1 interaction by administering an effective amount of agents for blocking ICAM sites of binding is provided. Also provided is a compound for blocking RSV-ICAM-1 interaction including an agent for blocking ICAM sites of binding.
REFERENCES:
Kumasaka et al., J. Clin. Invest. 97:2362-2369, 1996.*
Sly, P.D. and M.E. Hibbrt “Childhood asthma following hospitalization with acute viral bronchiolitis in infancy”Pediatr. Pulmonol.,1989, 7:153-158.
Staunton, D.E. et al. “Internalization of a major group human rhinovirus does not require cytoplasmic or transmembrane domains of ICAM-1”J. Immunol.,1992, 148:3271-3274.
Staunton, D.E. et al. “A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses”Cell,1989, 56:849-853.
Stott, E.J. et al. “Immune and histopathological responses in animals vaccinated with recombinant vaccinai viruses that express individual genes of human respiratory syncytial virus”J. Virol.,1987, 61:3855-3861.
Taylor, G. et al. “Respiratory syncytial virus infection in mice”Infection and Immunity,1984, 43:649-655.
Tomassini, J.E. et al. “cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1”Proc. Natl. Acad. Sci. USA,1989, 86:4907-4911.
Vignola, A.M. et al. “HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis”Am. Rev. Respir. Dis.,1993, 148:689-694.
Xu, H. et al. “Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice”J. Exp. Med.,1994, 180:95-109.
Hegele, R.G. et al. “Persistence of respiratory syncytial virus genome and protein after acute bronchiolitis in guinea pgis”Chest,1994, 105:1848-1854.
Hus, S.C. et al. “Reduction of respiratory synchytial virus titer in the lungs of mice after intranasal immunization with a chimeric peptide consisting of a single CTL epitope linked to a fusion peptide”Virology,1998, 240:376-381.
Huguenel, E.D. et al. “Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1”Am. J. Respir. Crit. Care Med.,1997, 155:1206-1210.
Jeng, M.J. and Lemen, R.J. “Respiratory syncytial virus bronchiolitis”Am Fam. Physician.,1997, 55:1139-1146.
Kelly, K.J. et al. “Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury”J. Clin. Invest.,1996, 97:1056-1063.
Kumasaka, T. et al. “Role of the intercellular adhesion molecule-1 (ICAM-1) in endotoxin-induce pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice”J. Clin. Invest.,1996, 97:2362-2369.
Levine, S. et al. “Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus”J. Gen. Virol.,1987, 68:2551-2524.
Li, X. et al. “Protection against respiratory syncytial virus infection by DNA immunization”J. Exp. Med.,1998, 188:681-688.
Makgoba, M.W. et al. “Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicity”Eur. J. Immunol.,1998, 18:637-640.
Olmsted, R.A. et al. “Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: Comparison of the individual contributions of the F and G glycoproteins to host immunity”Proc. Natl. Acad. Sci. USA,1986, 83:7463-7466.
Openshaw, P.J.M. “Immunity and immunopathology to respiratory syncytial virus”Am. J. Res. Crit. Care Med.,1995, 152:S59-S62.
Saito, T. et al. “Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells”J. Infect. Dis.,1997, 175:497-504.
Sligh, J.E. et al. “Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1”Proc. Natl. Acad. Sci USA,1993, 90:8529-8533.
Almenar-Queralt, A. et al. “Apical topography and modulation of ICAM-1 expression on activated endothelium”Am. J. Pathol.,1995, 147:1278-1288.
Anderson, J.J. et al. “Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection”J. Gen. Virol.,1990, 71:1561-1570.
Becker, S.W. et al. “RSV infection of human airway epithelial cells causes production of the β-chemokine RANTES”Am. J. Physiol.1997, 272 (Lung Cell. Mol. Physiol. 16):L512-520.
Behera, A.K. et al. “Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells”Bichem. Biophys. Res. Commun.,1998, 251:704-709.
Bella, J. et al. “The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand”,Proc. Natl. Acad. Sci. USA,1998, 95:4140-4145.
Casanovas, J.M. et al. “A dimeric crystal structure for the N-terminal two domains of intercellular adhesion molecule-1”Proc. Natl. Acad. Sci. USA,1998, 95:4134-4139.
Center for Disease Control and Prevention, “Respiratory syncytial virus activity—United States, 1996-1997 season”,MMWR,Dec. 6, 1996, 45(48):1053-1055.
Chini, B.A. et al. “Essential roles of NF-κB and C/EBP in the regulation of intercellular adhesion molecule-1 after respiratory syncytial virus infection of human respiratory epithelial cell cultures”J. Virol.,1998, 72:1623-1626.
Collins, P.L. “The molecular biology of human respiratory syncytial virus (RSV) of the genus Pneumovirus” in The Paramyxoviruses. D.W. Kingsbury, Editor, Plenum, New York, 1991, Chapter 4, pp. 103-162.
Fixler, D.E. “Respiratory syncytial virus infection in children with congenital heart disease: A review”Ped. Cardiol.,1996, 17:163-168.
Graham, B.S. “Pathogenesis of respiratory syncytial virus”Am. J. Respir. Crit. Care Med.,1995, 152:S63-S66.
Graham, B.S. et al. “Primary respiratory syncytial virus infection in mice”J. Med. Virol.,1988, 26:153-162.
Greve, J.M. et al. “The major human rhinovirus receptor is ICAM-1”Cell,1989, 56:839-847.
Armstrong, D.S. and S. Menahem “Cardiac arrythmias as manifestation of acquired heart disease in association with pediatric respiratory syncytial virus infection”J. Ped. Child Health,1993, 29:309-311.
Arnold, R.H. et al. “Expression of adhesion molecules (ICAM-1, LFA-3) on human epithelial cells (A549) after respiratory syncytial virus infection”Int. Arch Allergy Immunol.,1995, 107:392-393.
Becker, S. et al. “Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1 and interleukin-1 and interleukin-6”Am. J. Respir. Cell Mol. Biol.1993, 8:20-27.
Burke and Olson “Preparation of clone libraries in yeast artificial-chromosome vectors” in Methods in Enzymology, vol. 194, “Guide to Yeast Genetics and Molecular Biology” eds. C. Guthrie and G. Fink, Academic Press, Inc., Chap. 17, pp. 251-270 (1991
Behera Aruna
Kumar Mukesh
Matsuse Hiroto
Mohapatra Shyam S.
Saliwanchik Lloyd & Saliwanchik
Scheiner Laurie
University of South Florida
LandOfFree
Interrupting the interaction of intercellular adhesion... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interrupting the interaction of intercellular adhesion..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interrupting the interaction of intercellular adhesion... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3436067